Clinical Trial Update: Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial in breast cancer patients assessing electroacupuncture to prevent chemotherapy-induced nausea and vomiting, in conjunction with an olanza…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Jiuda Zhao | Conditions: Electroacupuncture, Olanzapine-contained Four-drug Antiemetic | Phase 3 | Status: RECRUITING